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Abstract
Background: Despite global progress in the fight to reduce maternal mortality, HIV-related maternal deaths remain
persistently high, particularly in much of Africa. Lifelong antiretroviral therapy (ART) appears to be the most effective way to
prevent these deaths, but the rates of three key outcomes—ART initiation, retention in care, and long-term ART
adherence—remain low. This systematic review synthesized evidence on health systems factors affecting these outcomes in
pregnant and postpartum women living with HIV.
Methods: Searches were conducted for studies addressing the population of interest (HIV-infected pregnant and
postpartum women), the intervention of interest (ART), and the outcomes of interest (initiation, adherence, and retention).
Quantitative and qualitative studies published in English since January 2008 were included. A four-stage narrative synthesis
design was used to analyze findings. Review findings from 42 included studies were categorized according to five themes:
1) models of care, 2) service delivery, 3) resource constraints and governance challenges, 4) patient-health system
engagement, and 5) maternal ART interventions.
Results: Low prioritization of maternal ART and persistent dropout along the maternal ART cascade were key findings.
Service delivery barriers included poor communication and coordination among health system actors, poor clinical
practices, and gaps in provider training. The few studies that assessed maternal ART interventions demonstrated the
importance of multi-pronged, multi-leveled interventions.
Conclusions: There has been a lack of emphasis on the experiences, needs and vulnerabilities particular to HIV-infected
pregnant and postpartum women. Supporting these women to successfully traverse the maternal ART cascade requires
carefully designed and targeted interventions throughout the steps. Careful design of integrated service delivery models is
of critical importance in this effort. Key knowledge gaps and research priorities were also identified, including definitions
and indicators of adherence rates, and the importance of cumulative measures of dropout along the maternal ART cascade.
Citation: Colvin CJ, Konopka S, Chalker JC, Jonas E, Albertini J, et al. (2014) A Systematic Review of Health System Barriers and Enablers for Antiretroviral Therapy
(ART) for HIV-Infected Pregnant and Postpartum Women. PLoS ONE 9(10): e108150. doi:10.1371/journal.pone.0108150
Editor: Gabriele Fischer, Medical University of Vienna, Austria
Received April 1, 2014; Accepted August 25, 2014; Published October 10, 2014
This is an open-access article, free of all copyright, and may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for
any lawful purpose. The work is made available under the Creative Commons CC0 public domain dedication.
Data Availability: The authors confirm that all data underlying the findings are fully available without restriction. All data are available within the published
studies that were used in the systematic review.
Funding: This review was supported by funding from the Africa Bureau of USAID. Three co-authors on the paper are from USAID. They played a role in designing
the review questions and methods, and contributed to revisions of the manuscript. They were not involved in data collection and analysis or drafting of the initial
manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* Email: cj.colvin@uct.ac.za
Background
Despite global progress in the fight to reduce maternal mortality
over the last 20 years, HIV-related maternal deaths remain
persistently high [1,2], with approximately 24 percent of deaths in
pregnant and postpartum women in sub-Saharan Africa attribut-
able to HIV [3]. Lifelong antiretroviral therapy (ART) appears to
be the most effective way to prevent HIV-related maternal
mortality [4]. Although ART is increasingly available in the public
sector health services of most countries, many pregnant or
postpartum women continue to struggle to access treatment, and
the rates of initiation, retention in care, and long-term adherence
remain troublingly low [5,6].
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This is surprising not only because of the increasing availability
of ART, but also because pregnant women represent a sector of
the population that is among the most consistently engaged with
the health system. Why are HIV-infected pregnant and postpar-
tum women continuing to die from HIV-related causes when
effective ART and prevention of mother-to-child transmission
(PMTCT) programs are increasingly available? What prevents
these women from accessing treatment during and after pregnan-
cy?
There is a large and growing literature on health systems
barriers to and enablers of ART. This literature has identified a
wide range of key factors, including long waiting times, transport
costs, fears of confidentiality breaches, poor staff attitudes and
fragmented service delivery platforms [7–10]. Many of these
factors also affect pregnant or postpartum women who need ART.
In this review, we examined the challenges specific to providing
ART to pregnant women 1) who may or may not already be
engaged with other health services (i.e., antenatal care or PMTCT
programs) and 2) who may be more vulnerable or have specific
health needs associated with their pregnancy and up to one year
after delivery.
This review is one of three systematic reviews that together
consider evidence around efforts to reduce mortality among HIV-
infected pregnant and postpartum women. The current review
examines the health system (or supply-side) barriers to and
enablers of three key outcomes among pregnant and postpartum
women: ART initiation, retention and adherence and evidence on
health system interventions that may facilitate access to maternal
ART. A second review synthesizes evidence on demand-side
barriers and enablers to ART [11]. ‘Demand-side’ factors include
those individual, interpersonal, community, and structural factors
outside of the health system that influence an HIV-infected
woman’s ability to initiate and adhere to ART. The third review
assesses the evidence on the effectiveness of various interventions




We conducted a systematic review of qualitative and quantita-
tive evidence regarding health system barriers and enablers of
access to ART for HIV-infected pregnant and postpartum women.
For the analysis of study findings, we used a four-stage narrative
synthesis design [13] that was informed by the World Health
Organization (WHO) health systems strengthening [14] and
Supporting the Use of Research Evidence (SURE) frameworks
[15], with comparative case analyses across a range of possible
contextual factors.
Study Eligibility
Inclusion Criteria. To maximize the breadth of data
included in the review, we included any study that reported
empirical qualitative or quantitative findings relevant to the review
question. Studies from low- and middle-income countries
(LMICs), as well as high-income countries, were included, as
were studies conducted in community, primary care or tertiary
care settings. Due to time and resource constraints, we only
included studies written in English. To maximize the relevance of
the study findings to current maternal ART policy and practice,
we only included studies published between January 1, 2008 and
March 26, 2013.
Exclusion Criteria. We excluded studies that focused only
on PMTCT vertical transmission outcomes or that included only
PTMCT or maternal ART program outcomes but did not identify
or discuss the related health systems barriers or enablers. We also
excluded studies on broader cohorts of people with HIV (e.g., all
adults on ART) if barriers and enablers specific to pregnant or
postpartum women could not be distinguished in the findings.
Search Strategy and Selection Process
Search strategy. To identify eligible studies, we first
searched for peer-reviewed publications through the PubMed
and Social Science Citation Index databases. For the database
searches, we used variations of search terms for 1) the population
of interest (pregnant or postpartum women with HIV, 2) the
intervention of interest (antiretroviral therapy) and 3) the outcomes
of interest (initiation, adherence, retention). A full search strategy
for one of the database searches can be found in the Supporting
Information. Additional studies were identified through a gray
literature search of conference abstracts, program reports, and
government documentation related to ART for HIV-infected
pregnant or postpartum women. A list of websites searched for
gray literature can be found in the Supporting Information.
Study selection. Studies were selected for review in two
stages. First, three review authors independently assessed the first
100 abstracts retrieved from PubMed. Each reviewer’s list of
selected articles and accompanying rationale was compared with
the list from the other reviewers; discrepancies were discussed and
resolved. Inclusion and exclusion criteria were refined and clarified
during this process.
Quality Assessment and Data Extraction
Characterizing the evidence base. Given the diversity of
study designs included and the difficulty of comparing study
quality assessments across widely varying study types, we
addressed study quality in two separate steps. First, we developed
an overview of key characteristics of the evidence base by
summarizing several variables, including study design, sample
size, geographic region, healthcare setting, and risk of bias (see
Supporting Information). We ranked each included study as low,
medium or high with respect to overall risk of bias, based on its
sample size, selection criteria, sampling procedure and data
analysis method. Rankings of study quality were based on criteria
relevant to each study design and were justified with a short
narrative (see Supporting Information). This provided an overview
of the quality of the existing evidence base, as represented by the
included studies. No studies were excluded on the basis of the
quality assessment. Rather the quality assessment process was used
to identify weaknesses in study methodologies and to strengthen
interpretation and assessment of study findings.
In the second step, we used the summary of evidence-based
characteristics to assess the strength and generalizability of the
evidence underlying the key review findings. This step is described
in more detail in the Data Synthesis sub-section below.
Data extraction and management. Following study selec-
tion, one review author (SK) extracted data from the studies using
a standard template. Initial data extraction captured both the
study characteristics (e.g., setting, participants, type of ART
program reviewed) as well as key findings related to program
outcomes and factors relating to initiation, retention, and
adherence. A second author (CC) also reviewed the studies and
extracted data relating to program outcomes and key health
systems factors. Extracted findings from both authors were
compared and discrepancies resolved.
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Data synthesis
The reviewers synthesized the evidence using a broadly
comparative case-study approach informed by tools and tech-
niques outlined in the narrative synthesis framework (see
Supporting Information for a fuller explanation) [13]. The first
step in this approach was developing a preliminary synthesis of the
findings using an initial conceptual framework. To develop this
framework, we drew from three sources: the WHO’s health system
‘building blocks’ model [14], the SURE framework for identifying
barriers and enablers to implementing health interventions [15],
and a three-day scoping meeting held with all of the reviewers at
the beginning of the project to refine the conceptual framework
and ensure shared understanding of the key areas of interest for
the review.
In the second step of the synthesis, two reviewers used this initial
conceptual framework to guide the extraction of data and the
identification of key barriers and enablers to maternal ART access.
Emerging themes were discussed and refined throughout the data
extraction process. One author synthesized these barriers and
enablers into an overall framework of overarching themes and key
findings that was then reviewed by the other reviewers for
accuracy and comprehensiveness.
The third step explored whether certain independent factors
related to the intervention or the context moderated the effect of
the identified enablers and barriers. We examined differences
between rural and urban settings, between routine and pilot/
demonstration project settings, between various ART and
PMTCT protocols and regimens, by co-morbidity, and by age
group. We also explored the findings for other unanticipated
associations.
The review findings were then organized into five themes, four
descriptive and one related to interventions. Within each broad
theme, we then identified one to four ‘‘key review findings.’’ In the
narrative below, we also describe the individual findings that led to
the development of that key finding.
In the fourth step of the narrative synthesis, we assessed the
strength of the evidence for each of the ‘‘key review findings’’ and
considered the extent to which these findings could be generalized.
For each key review finding, we looked back at the studies that
contributed to that finding and considered: 1) how strong the
underlying study design was, 2) what the risk of bias was, 3) what
level of detail and/or context was provided to enable interpreta-
tion, and 4) how frequently the review finding was found across the
individual studies. We then ranked the strength of the evidence
underlying each finding as strong, moderate or weak. We were
also interested in the generalizability of the key review finding with
respect to public sector health services in low and middle-income
countries with high HIV prevalence. For each key review finding,
we therefore asked two additional questions: 5) how many of the
studies supporting this finding were conducted within existing
services settings, and 6) how many came from LMICs with high
HIV prevalence. Here too, we ranked generalizability as strong,
moderate or weak.
In the summary table of key review findings (see below), we
provide these rankings along with a very brief narrative
justification for each. In the Supporting Information, we provide
a fuller description of this method and justify our rankings by
summarizing our answers to the above questions in more detail.
While this assessment is narrative rather than quantitative, the
fuller description of how the six questions were answered and the
rankings were determined strengthens accountability and trans-
parency and enables independent review of our assessment.
Results
Overview of Studies Included and ART Programs and
Outcomes
A total of 2,159 titles and abstracts were identified for screening;
42 papers and conference abstracts were included in the full review
[16–57]. See Figure 1 for a flow diagram of the search and
inclusion process and Table 1 for a summary of the studies
included.
The vast majority of the studies included were conducted in sub-
Saharan Africa, in rural or both rural and urban settings, used
clinical epidemiology study designs, and addressed ART initiation
as the primary outcome of interest. Study participants included
HIV-infected pregnant and/or postpartum women and/or health
care providers delivering antenatal care (ANC), ART and/or
PMTCT. A few studies included partners and/or family members
of HIV-infected pregnant or postpartum women.
Most of the studies were from service delivery settings that used
triple therapy antiretroviral (ARV) prophylaxis for the mother, or
initiation of lifelong ART if CD4 ,350. Eight studies were from
settings using a single-dose nevirapine (sdNVP) protocol and two
studies reported results from programs using the Option B+
protocol (initiation of lifelong ART regardless of CD4 level). Only
12 studies formally tested an intervention related to maternal
ART. A table listing the characteristics of the included studies can
be found in the Supporting Information.
Given the importance of maintaining adherence to treatment
regimens, only nine (21 percent) of the included studies assessed
either short- or long-term ART adherence, with three studies
conducted in settings that used the outdated sdNVP protocol. To
measure adherence, the studies used a variety of indicators as there
was a lack of a uniform definition. Table 2 summarizes the wide
variety of indicators used in the studies to measure adherence.
Overview of Health Systems Barriers and Enablers
Identified
We divided the review findings into five descriptive themes: 1)
models of care, 2) service delivery, 3) resource constraints and
governance challenges, 4) patient/health system engagement, and
5) interventions to improve maternal ART outcomes. There are
one to four ‘‘key findings’’ under each theme which are
summarized in Table 3. The table also identifies the strength
and generalizability of the evidence (See the Supporting Informa-
tion for a fuller narrative justification of these assessments).
In many cases, studies included important contextual informa-
tion about health systems barriers and enablers that helped to
explain their findings or added their own new information. We
included information from both the findings and discussion
sections of the studies. Discussion-related data was considered to
be of less reliability than that reported under findings.
Throughout the findings and discussion below, we also refer to
the ‘maternal ART cascade’ to signify the multiple steps women
must move through to initiate, be retained and/or remain
adherent on ART. We distinguish the maternal ART cascade
from the more commonly used ‘PMTCT cascade’ precisely
because the steps that HIV-infected mothers must move through
to initiate and remain adherent on ART for their own health are
often broader and somewhat different than those maternal ART-
related steps that are part of the PMTCT cascade (see Theme 1
below). Figure 2 captures some of the key steps women must move
through in order to maintain successful treatment for their HIV
infection, with the figure organized into key cascade outcomes in
the movement along a path towards treatment and the component
steps that are necessary to achieve each outcome.
Health System Barriers and Enablers for ART for HIV+ Women
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Two further points about the cascade are important. First, each
sub-step in the cascade is itself potentially quite complex. Even
something as straightforward as having a CD4 test (one step in
ART assessment) is multi-faceted. This step requires that providers
remember the need for testing and offer testing to the client; that
tests are available; that women accept the test; that the tests are
available at the time and place they need to be done; that the client
actually undergoes the test; and that the results are produced and
made available by the clinic in a timely manner. Second, although
the first step of this cascade begins with ‘Access to the Health
System’, it is essential to remember that many women who are
pregnant and HIV-infected do not access the health system early
enough in their pregnancy to go through all the steps of the
cascade. Issues related to this ‘total at-risk population’ are
discussed in subsequent sections of this paper.
Theme 1: Models of Care
Service integration and models of care. This theme
explores questions about the design of various healthcare service
delivery models and the extent to which they support ART uptake,
retention and adherence for pregnant and postpartum women
with HIV. The key issue of concern in most of the studies was the
degree of integration between ART and maternal health services
and the impact of different models of integrated care on outcomes.
The studies reviewed described various models of care for HIV-
infected pregnant women that represent differing relationships
between adult ART and maternal health service integration. One
study [42], for example, provided a useful typology of models for
the integration of ART and ANC services, describing:
N ‘integrated’ models, where adult ART and ANC services were
fully integrated,
Figure 1. Flow Diagram for Study Search and Inclusion.
doi:10.1371/journal.pone.0108150.g001
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N ‘proximal’ models, where adult ART and ANC services were
separate but situated close to one another, usually in the same
facility, and;
N ‘distal’ models, where adult ART and ANC services were
located at different facilities, requiring both referral and travel
for patients.
While many studies referred to the benefits of integrated
models, only four of the studies compared two or more models of
integration. Two of the studies found little difference in ART
initiation between integrated, proximal and/or non-integrated
models [42,43]. Tsague et al. [43], however, found that women at
the integrated ‘full-package’ sites were significantly more likely to
be enrolled in HIV care and assessed for ART but no more likely
than women at PMTCT-only ‘stand-alone’ sites to initiate ART.
Two other studies found substantially improved initiation when
services were integrated [53,55]. The studies that found little
difference in outcomes between the different models of care had
small sample sizes and were conducted within existing services
using routinely collected health data. Neither was powered nor
designed to be a rigorous test of alternative models. The two
studies that found differences were more rigorously designed and
better powered. However, they were set within a more carefully
supported and protected, and therefore, less typical context. Thus,
findings from these studies are less generalizable and the models
may be more difficult to scale up without substantial resources.
The researchers who found little evidence of a positive effect
from integration were surprised by their findings and speculated
that factors unrelated to integration could have been at work.
Stinson et al. [42] point to chronic human resource shortages,
rigid protocols, and lengthy drug readiness training requirements
as reasons integrated clinics did not do significantly better than
others. Tsague et al. [43] argue that broader improvements within
the health system with respect to CD4 testing, healthcare worker
training and strong patient follow-up may have reduced the
Table 1. Summary of Characteristics of Included Studies.
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observed differences between the ‘full-package’ and ‘stand-alone’
sites they investigated.
Both of these studies demonstrate that the design of effective
models of care for delivering maternal ART requires the
consideration of a multiple factors, in addition to integration
(See Table 3, Key Review Finding 1a). In order to provide a richer
understanding of the ways broader service design factors may
affect ART outcomes, we have extracted aspects of service delivery
that were identified frequently as important in the included
studies. Rather than list all of these factors as a set of bullet points,
we have reframed them as a set of questions designers or
evaluators of health services would need to answer in order to
develop an effective model of care, regardless of the degree of
integration of services. These questions are presented in the first
column of Table 4.
The second column in Table 4 summarizes some of the
implications of particular design choices for maternal ART, as
described in the included studies. The three issues that comprise
the third, fourth and fifth columns of the table relate to cross-
cutting factors identified in the studies that constrain the kinds of
design choices that are possible. Resource constraints can make
some choices less tenable, opportunity costs may make some
choices less desirable, and policy and political barriers to change
may make some choices less feasible.
Inconsistent attention to maternal ART. One key recur-
ring theme in several of the included studies was a loss of focus on,
or prioritization of, maternal ART within ANC, PMTCT and
HIV programs (See Table 3, Key Review Finding 1d). There were
frequent references to the perception that, in the process of
prioritizing the prevention of vertical transmission, management of
the mother’s HIV infection was relatively neglected, often to the
longer-term detriment of the health of both mother and child.
One study [46] found that adult ART services sometimes
refused to enroll pregnant women with HIV on the assumption
that they were healthy enough to wait for assessment until after
delivery. One clinic in that same study even reported that HIV
nurses would turn pregnant women away on the mistaken
assumption that they had already received the appropriate HIV
treatment and care—either ART for their own health or as
prophylaxis—in the PMTCT program. These two examples
reflect the findings of a number of other studies [18,30,47,53].
The unique needs of HIV-infected pregnant and postpartum
women also appeared not to be well-accommodated by HIV and
maternal health services. Several studies found that postpartum
women were particularly difficult to retain in care, given the
demands they faced caring for a newborn, given that many
maternal health sites offered few postpartum services, and given
that many ANC sites had weak referral systems to adult ART
services. Antenatal services were generally described as discon-
nected from non-pregnancy related services such as general
pediatric care or general HIV care, and there was a high rate of
dropout both from the health system more generally, and from
ART specifically around the intrapartum period. For their part,
adult HIV services also did not seem to take into account the many
social, physical and emotional challenges that mothers faced
during the postpartum period [16,19,27,30,31,36].
Similarly, two studies reported that women, whose CD4 counts
were too high to beeligible for lifelong ART at the time of testing
or who refused lifelong ART during pregnancy, had a very high
postpartum dropout rate and therefore merited special attention.
Ideally, these women would have been retained in HIV care to
support their health, address opportunistic infections, and be
regularly re-assessed for ART eligibility [19,20].
Finally, most of the models of care that were reviewed
neglected, or actively excluded, male partners of pregnant or
postpartum women from participating in maternal health services,
especially ANC and HIV care. It is often difficult to include male
partners in HIV testing and treatment sites for women, especially
in the antenatal context of HIV care for pregnant women
[18,22,23,26,32,36]. HIV services, thus, often failed to adequately
retain or include a range of relevant sub-groups in care—including
postpartum women, ART-ineligible and ART-declining women,
and their male partners. (See Table 3, Key Review Finding 1c)
Persistent service gaps and maternal ART cascade
dropout. Even when new models of care were carefully
designed to support pregnant or postpartum women’s access to
ART and overcome typical access barriers, such as those related to
vertical services and physical distance, long wait times, and fears
about loss of confidentiality, dropout along the maternal ART
cascade often remained a persistent problem (see Table 3, Key
Review Finding 1b).
Several studies described services that were located next to each
other (proximal models of integration) but remained poorly
coordinated due to barriers such as communication and failures
in coordination, or bottlenecks related to the delivery of lab results.
In some cases, poor service delivery was the result of integrating
Table 2. Indicators of Adherence Used in the Studies.
Study Adherence Indicator
Awiti [16] Measure of adherence and type (short/long term, etc.) not noted; duration on ART was between 1 and 6 years, self-reported
Ayuo [17] Measure: disengagement (early disengagement = no contact for any period of 30 or more consecutive days between first antenatal visit and
delivery; late disengagement = no contact during the 30 days prior to delivery); self-reported adherence
Delvaux [22] Adherence defined as mother-infant pairs who ingested SD-NVP at recommended time; non-adherence = not ingesting at all or at wrong time
Kasenga [26] Unclear
Kirsten [27] Adherence to combination prophylaxis for PMTCT (AZT at week 28, sdNVP) assessed drug collection, dispensing (pre and postpartum) and
ingestion (during delivery/hospitalization)
Kuonza [28] Adherence to sdNVP; non-adherence includes those who did not ingest or those that took at the wrong time; study also looks at infant adherence
and combined maternal-infant adherence
Mellins [30] Adherence based on self-report, having taken all doses in two prior days; also asked to report on last missed dose (past week, past two week, past
month, past three months, more than three months ago, never)
Nassali [36] Adherence to prenatal PMTCT program measured as proportion of mothers who honored appointments by end of 8 weeks postpartum
Peltzer [39] Adherence to sdNVP; self-reported
doi:10.1371/journal.pone.0108150.t002
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Table 3. Summary of Key Findings and Underlying Evidence.
MAJOR THEMES AND KEY FINDINGS STRENGTH OF THE EVIDENCE GENERALIZABILITY OF THE EVIDENCE
Theme 1: Models of Care
a) Maternal ART services struggle to retain women in
care and involve their partners, especially during the
postpartum period and when women are ART-ineligible
or have declined ART.
Strong Several high-quality studies
with good detail reported this
finding
Strong Reported in both a wide variety of clinical
settings and geographic regions
b) Gaps between ANC/PMTCT and HIV services and dropout
along the maternal ART cascade are persistent, widespread
problems, even when models of care are designed to
overcome typical access barriers such as vertical programs,
physical distance, wait time, and fears of confidentiality.
Strong Detailed reporting in many
studies, both quantitative
and qualitative
Strong Reported in many contexts, especially routine
settings
c) The design of effective models of care for delivering
maternal ART involves many more consideration than the
degree of integration.
Strong Evidence that integration
effects are mixed and are
determined by many factors is found
in many studies of all qualities
Moderate Reported in several contexts, especially
relevant in settings with weak health systems
d) Maternal ART has been under-prioritized in ANC,
PMTCT and HIV programs.
Weak Often reported but
mostly second-order interpretations
Moderate Reported in several different contexts
Theme 2: Service Delivery
a) Dropout from and delays in the maternal ART
cascade are exacerbated by a range of communication
and coordination problems, including scheduling
difficulties, poor follow-up and tracing of patients,
weak information systems, and failure to keep up
with rapidly changing treatment protocols and referral
procedures.
Strong Detailed reporting in
multiple well-designed studies
Strong Reported in many contexts, especially routine
settings
b) Dropout from and delays in the maternal ART cascade
are driven by problems in delivering HIV services in the
context of ANC programs, including poor access to
HIV testing, poor pre-/post-test counseling, lack of
POC CD4 testing, and lengthy, rigid or complicated
treatment protocols that made caring for sick or
late presenting women more difficult.
Moderate Some elements of
the finding stronger than others
(e.g. CD4 testing), not much detail
provided but consistent as a theme
Strong Finding reflected in many routine settings with
high prevalence and weak health systems
c) Dropout from and delays in the maternal ART
cascade were worsened by weak training and
supervision of healthcare workers in the areas of
emotional support (both for themselves and their patients)
as well as up-to-date information on treatment protocols,
referral procedures, and the importance of maternal
HIV care.
Weak Reported by a few studies,
often second-order interpretation
with little detail on context
Moderate Finding reflected in some routine settings
with weak health systems
Theme 3: Resource Constraints and Governance Challenges
a) System-wide resource constraints that inhibit the
access of those using health services, including human
resources shortages and turnover, long waiting times,
supply shortages and supply chain problems, and user
fees, can pose an even greater barrier to accessing
ART for pregnant women.
Moderate Widely reported in
studies with high and low risk of
bias but little context given on
reasons behind barriers
Strong Widely reported in routine settings with weak
health systems
b) Governance challenges in the broader health system,
including centralized resource allocation, poor performance
management and weak and fragmented accountability
mechanisms, inconsistent payment processes, and the
ineffective management use of health information,
can exacerbate health service delivery problems at
the facility level, especially for the services aimed
at HIV-infected pregnant and postpartum women
which are already fragmented, inefficient and
poorly coordinated.
Weak Addressed in only a
few studies, mostly second
order interpretation but in
studies with low risk of bias
Moderate Reported in a few studies in routine settings,
consistent with other known barriers but little context
provided
Theme 4: Patient/Health System Engagement
a) There are many different aspects of the relationship
between healthcare workers and HIV-infected pregnant
women that have an effect on initiation, retention and
adherence to maternal ART, including nature of
confidentiality within the relationship, HIV-related
stigma, favoritism, unequal power relationships,
and perceptions about the healthiness of pregnant women.
Strong Widely reported in
studies of varying quality, both
qualitative and quantitative,
often with adequate detail on
context
Strong Reported in many studies in a wide range of
settings, including routine settings
b) The success of efforts to initiate and retain HIV-infected
pregnant women in ANC and HIV care was shaped by the
directness, intensity, frequency, and extension of provider
engagement with women.
Moderate Reported in several
high-quality studies but not much
detail on context, often
second-order interpretations
Weak Reported in several studies but effects of factors
varied
Health System Barriers and Enablers for ART for HIV+ Women
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some aspects of care (for example, including HIV testing as part of
ANC care) without attending to broader system weaknesses (such
as the poor availability of test kits) [5,17,19,42,43,53].
Task shifting is an approach to addressing the shortage in
human resources. In several studies, rigid task allocation and
treatment protocols that prevented nurses from initiating ART
were identified as significant barriers to access [42]. However,
task-shifting can also present challenges when not carefully
considered and supported. One study also found that task shifting
could contribute to more fragmented care by shifting HIV testing
to lay counselors, thereby complicating the ANC care pathway
between nurse and patient, and increasing workloads [57].
Breaches in confidentiality that resulted from fragmented
services emerged as a barrier to access as well. In two studies,
separate waiting rooms and the use of different types of medical
forms for those accessing HIV care led to fears around the
identification of those receiving HIV care [16,18]. Other studies
found that outreach efforts intended to improve patient follow-up
(such as home visits or food baskets for new mothers) threatened
confidentiality, and thus, retention in care [18].
There were several studies that discussed models of integration
that were able to improve retention throughout the maternal ART
cascade. Killam et al. and Ramers et al. both reported that
integration of ART services into ANC roughly doubled the
number of eligible women initiating ART [53,55]. Weigel et al.
described a multi-faceted intervention to improve linkages
between HIV and ANC services that similarly improved ART
initiation and retention [47]. This intervention included provider-
initiated testing and counseling, queue prioritization, same-day
blood collection for CD4 testing, and ‘fast-tracked’ ART initiation.
No one model of care included in this review was able to fully
address all of the barriers to initiation, retention and adherence. In
most of the studies, health services failed to adequately enable and
support ART initiation and retention for the majority of pregnant
or postpartum women. The more effective models ensured
coordination among various components of the system and
focused specifically on overcoming the challenges associated with
treating HIV-infected pregnant and postpartum women, and in
particular, the period of transition between pregnancy and post-
partum periods for individual women.
Theme 2: Service Delivery
This theme addresses the day-to-day management and opera-
tion of service delivery. The included studies described a wide
range of service delivery factors that affected initiation, adherence,
and retention. Most of the reported issues involved poor
communication and coordination, but there were also problems
with the quality of clinical practices and significant gaps in training
and supervision. While some of these problems reflected weak-
nesses in the broader health system, many of them were either
specific to or intensified by the unique challenges of providing
ANC and PMTCT services to this population.
Communication and coordination problems. A wide
range of the included studies reported that dropouts and delays
in the maternal ART cascade were often the result of commu-
nication and coordination problems, including scheduling diffi-
culties, poor follow-up and tracking of patients, weak information
systems, and failure to effectively communicate rapidly changing
treatment protocols and referral procedures throughout the health
system (See Table 3, Key Review Finding 2a).
Table 3. Cont.
MAJOR THEMES AND KEY FINDINGS STRENGTH OF THE EVIDENCE GENERALIZABILITY OF THE EVIDENCE
Theme 5: Interventions to Improve Maternal ART Outcomes
a) While there may be any number of quick wins for
improving outcomes along the maternal ART cascade,
effective interventions typically move beyond integrating
discrete elements of service delivery, and instead, provide
multi-pronged and multi-leveled interventions in the
broader health system to support maternal ART initiation,
retention and adherence.
Strong Several studies with
low risk of bias and sufficient
detail across several intervention
categories confirmed the finding
Strong Reported in several studies in routine settings,
sufficient detail available.
doi:10.1371/journal.pone.0108150.t003
Figure 2. The Maternal ART Cascade.
doi:10.1371/journal.pone.0108150.g002
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Scheduling difficulties of all kinds appeared in the studies and
were driven by a variety of factors. Problems included overbook-
ing, cancelled bookings, failure to book on time, and services that
were available only on a very limited schedule [27,41,44]. Some of
the challenges posed by these scheduling issues were compounded
by demand-side factors such as late presentation for ANC services
or missing scheduled ANC visits that then threw off the often
rigidly scheduled ANC service schedules (detailed in the next
section) [19,35,45]. Other challenges were related to perceptions
among healthcare workers that pregnant women were relatively
healthy compared to other patients and could be among the first
patients to be sent home when the clinic was overcrowded [18].
When women did not show up for appointments, there were
often no systems in place to track and follow up with them to
ensure they continued to receive care. Women’s own perceptions
that they are healthy while pregnant and do not need care, and
their tendency to move to new locations during or after pregnancy
to access family support [17,24] compounded the challenge
associated with enabling their continued access to services. These
demand-side factors highlight weaknesses in the health system,
including its general orientation towards reactive engagement with
patients (i.e., waiting for them to present) and lack of coordination
across services and facilities. These weaknesses translated into few
mechanisms for either tracking women who dropped out of ANC,
PMTCT, postpartum services, or HIV care, or keeping track of
unplanned or unsuccessful referrals across facilities. Only a couple
of studies identified processes for quickly identifying and following
up on missed appointments (see Theme 5 and the Supporting
Information for more information on effective interventions)
[17,47].
The problems associated with scheduling, follow-up and referral
are largely generic to healthcare provision for pregnant women in
general, although the stigma associated with HIV adds a layer of
complexity. The reviewed studies also identified challenges for
communication and coordination which were specific to PMTCT
and ART programs. In particular, rapidly changing PMTCT and
ART protocols often outpaced the ability of the health system to
appropriately adapt. When new treatment protocols or changes in
models of care were introduced, they were often not fully planned
out at the level of day-to-day service provision and critical issues
such as workload distribution, task allocation, patient flow, and
record-keeping and appointment keeping systems were not
adjusted [29].
The slow and uneven diffusion of information about these rapid
changes in protocol through the health system was also noted in
several studies. Lack of awareness on the part of nurses about the
most recent changes in ART protocols, clinical practice guidelines,
and/or the organization of service delivery—in particular, referral
pathways beyond their facility—were identified in several studies
as barriers to effective clinical care and patient retention
[22,24,27,46].
Table 4. Considerations for Maternal ART Models of Care.
ASPECT OF MODEL OF CARE IMPLICATIONS FOR MATERNAL ART CROSS-CUTTING ISSUES
What kind of HIV testing is done, where
is it done, and by whom?
Opt out is better for uptake. Lay counselors are
more approachable but nurses provide more
continuity. There is better continuity if HIV










Where is ART assessment and
initiation done?
Referral and assessment is better in integrated
services, but it is not clear if initiation is better.
Who is allowed to initiate ART? The more cadres that can initiate ART, the more
flexible and responsive initiation can be.
How are lab services integrated
with ART assessment and initiation
services?
Point of Care CD4 testing can speed initiation.
What mechanisms (record-keeping,
appointment systems, peer escorts, etc.)
are used to ensure linkage across
different services?
More active linkages between services and follow
up/tracing (follow up by CHWs) result in fewer
drop-outs.
How are women transferred into
and out of adult ART services before
and after pregnancy?
For women already on ART, management of ART
while pregnant needs to be coordinated with
PMTCT program. For these women, and for
women not on ART before pregnancy, how they
are transferred back to general adult ART services
can impact retention and adherence.
How are the general adult ART
services organized?
More decentralized ART services, in general, make
linkages between ART and ANC services easier.
What is the intended pacing of
movement through the maternal
ART cascade?
Drug readiness, training, PMTCT protocols, and other
assumptions built into models of care can greatly
increase
or decrease the pace of movement through the
maternal
ART cascade, and thus, opportunities for drop-out.
Are CHWs, peer mentors or support
groups part of the model of care?
These cadres/interventions can provide better
psychosocial support for women throughout
the cascade, as well as contribute to coordination
of and linking across services.
doi:10.1371/journal.pone.0108150.t004
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In several contexts, weak systems for disseminating information
about new guidelines, policies and practices were identified as an
important underlying cause of many of these communication and
coordination challenges [31,33,37,41]. This weakness reflects
broader health system challenges.
Clinical service delivery issues. Dropout from and delays
in progression along the maternal ART cascade were also driven
by problems in delivering HIV services in the context of ANC
programs, including poor access to and quality of HIV testing, lack
of quick CD4 testing, and lengthy, rigid or complicated treatment
protocols that made caring for sick or late presenting women more
difficult (See Table 3, Key Review Finding 2b).
Several studies reported that rigid or inappropriate treatment
protocols could make it difficult for ANC, PMTCT or HIV
services to accommodate the needs of pregnant women or adjust
to their early or late presentation to the health service. One study
[27], for example, found women who presented early at ANC, in
their first trimester, had a higher risk of not initiating ART than
those who presented later since the protocol at the time (in 2008)
only allowed initiation of prophylaxis at 28 weeks. Most other
studies, however, reported a contrasting problem—PMTCT and
ART treatment protocols were multi-step and organized around
an assumption that women would present at the ‘right time’ for
ANC services [19,26,35]. Consequently women who presented
late had difficulty moving through all of the ART steps—
diagnosis, assessment, preparation, initiation and maintenance—
before delivery.
A number of studies reported that poor access to HIV testing
and poor quality of pre- and post-test counseling also were
significant barriers to women initiating ART. If testing is not easily
available to women during the ANC visits or if counseling is of
poor quality, women can be deterred from testing or pursuing
HIV care once diagnosed with HIV, missing important linkage
opportunities. In some situations, these testing barriers reflected
more generic problems with overall HIV testing services, but in
other cases, there were problems with access to and quality of HIV
testing specific to ANC settings [31,41,42]. The absence of high-
quality couples testing and counseling was also seen as a significant
barrier, especially to male partner involvement in ANC and
general HIV care [26,39]. A few studies reported that high-quality
HIV testing, prompted or opt-out HIV testing, and inclusive
couples counseling were significant enablers of ART uptake and
male involvement in ANC and PMTCT services [25,41,48].
Finally, the next step along the maternal ART cascade—
assessment—proved to be as difficult as the step discussed above.
Problems related to CD4 testing were reported as the next critical
barrier in movement along the cascade for women who were
referred to and successfully entered HIV care for assessment
[29,33,41,44,46]. In settings where point-of-care CD4 testing was
not available, blood samples had to be sent to offsite laboratories.
Both the time required for conducting tests and returning results
and frequently delayed or missing test results were critical barriers
to assessment, and thus initiating ART.
Training and supervision. Poor training and weak super-
vision were the third area identified as contributing to low quality
service delivery and drop out and delay along the maternal ART
cascade. Providers often did not have the requisite skills or
knowledge of current treatment protocols or referral procedures
for providing maternity care to HIV-infected women, and were
unprepared to provide emotional support to their clients.
Insufficient supervision also meant that the providers themselves
did not receive emotional and other requisite support (See
Table 3, Key Review Finding 2c).
Other aspects of PMTCT and HIV care for pregnant women
posed additional challenges to initiation, retention and adherence
[22,24,27,33,38]. Rapidly changing PMTCT and ART protocols
required frequent retraining and supportive supervision. Nurses
who were trained before the widespread availability of ART or
PMTCT were at a disadvantage but even more recently educated
healthcare workers sometimes struggled to maintain up-to-date
knowledge about treatment protocols and other aspects of clinical
care. Finally, reflecting a broader lack of focus on the health needs
of HIV-infected mothers, some antenatal healthcare workers were
reported as having insufficient awareness of the importance of
maternal ART, leading to a failure to encourage and follow-up on
HIV care for these women [30].
A few studies also reported on weak training and supervision for
nurses with respect to stress management and emotional support,
both for their patients and themselves [24,41,45]. This gap was
seen in the lack of preparation for responding to the special
emotional needs of pregnant women who often feel they are
healthy, are excited about their pregnancy, and yet, at the same
time, feel very concerned about their HIV status. Healthcare
workers’ often stigmatizing attitudes towards pregnant women
with HIV compound the challenge of providing emotional support
for these women. A lack of training and supervision, likewise, left
healthcare workers poorly prepared to manage their own stress
and feelings of cognitive dissonance about the co-presence of
pregnancy and HIV.
Theme 3: Resource Constraints and Governance
Challenges
The studies also reported a range of issues associated with
weaknesses in the broader health system, weaknesses that were
often the result of resource constraints and governance challenges.
Resource constraints. System-wide resource constraints
such as human resources shortages and turnover, supply shortages,
and poor supply chain infrastructure also could be barriers to
accessing ART for pregnant women (See Table 3, Key Review
Finding 3a). Human resource shortages and high staff turnover
were reported to have substantial effects on maternal ART
initiation, retention and adherence, largely because these factors
prevented effective continuity of care [18,24,31,41]. A number of
studies also reported supply shortages and supply chain problems
that affected maternal ART outcomes. Drug stock-outs or the
absence of sufficient numbers of HIV testing kits led to drop-out at
several points along the maternal ART cascade [39,41,54].
Some of the most common complaints from pregnant and
postpartum women were related to features of the health system
that can also be traced to these wider resource constraints. For
example, long waiting times was the most frequently cited barrier
to accessing HIV care in the included studies
[16,18,23,29,33,38,48]. Long waiting times were at least partly
the result of poor scheduling and management of patient flow in
most settings, and were also the result of deep and persistent
human resource shortages.
Long waiting times represented a particularly important barrier
for HIV-infected pregnant women for three reasons. First, some
studies reported that pregnant women were more likely to feel that
their pregnancy made them less able to wait for long periods of
time. Second, by contrast, many women, along with their families
and healthcare workers, perceived pregnancy to be a time of
health rather than illness, making long waiting times seem all the
more unnecessary. Finally, given the widespread association
between pregnancy and health, some women feared that spending
a long time at the clinic would raise questions among family and
community members about whether they were seeking HIV care.
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The fragmentation of ANC and HIV services exacerbated this
problem by compounding the total length of waiting time.
Health system governance. In addition to the effects of
resource constraints, some of the studies also reported a range of
broader health system governance challenges. The challenges
included overly centralized resource allocation, poor performance
management, weak and fragmented accountability mechanisms,
inconsistent payment processes, and the ineffective management
use of health information. These challenges exacerbated health
service delivery problems at the facility level, especially the services
for HIV-infected pregnant and postpartum women, which often
are already fragmented, inefficient and poorly coordinated (See
Table 3, Key Review Finding 3b).
Centralized resource allocation, for example, can act as a
barrier to effective maternal ART services at the facility level by
taking local-level spending flexibility away from lower levels of the
health system [41]. Similarly, poor performance management
processes, and weak and fragmented lines of accountability within
and between services (e.g., between ANC and HIV services)
sometimes made it difficult to identify problems in ART and ANC
service delivery and to respond appropriately and effectively
[23,27,41]. Even simple breakdowns in management systems, such
as inconsistent payments to healthcare workers, or more
frequently, to lay counselors conducting HIV counseling and
testing, could result in significant reductions in morale and quality
of care [41].
Another management weakness, linked to the weakness of
health information systems noted above, was that management
largely did not use health information for making decisions, in
allocating resources, or in accountability. Even when some form of
routine data was available to health managers, there was often a
failure to make use of this information for management purposes.
This lack of data use was especially true with information related
to maternal ART, reflecting again, the earlier key review finding
about insufficient focus on maternal ART [41,47,48].
Theme 4: Patient-Health System Engagement
This theme considers the engagements between HIV-infected
pregnant and postpartum women, and the range of providers in
health facilities, from clinicians to community health workers and
others. The ‘health system’ framework and the term ‘engagement’
are used here to signal a broader range of engagements than
‘patient-provider interaction’ alone. All forms of interpersonal
practice, perception and relationships that more broadly impact
women and their degree of ‘engagement’ with the health system
are discussed below.
Complexity of the patient-provider relationship. In
several studies, the relationships between the women and the
healthcare workers with whom they interacted were a rich source
of commentary and critique. While many studies reported
generically that ‘negative attitudes’ or disrespectful providers were
a barrier to care, there were also other important aspects of the
relationship between healthcare workers and HIV-infected preg-
nant and postpartum women that had an effect on initiation and
retention to maternal ART. These included the nature of
confidentiality within the relationship, HIV-related stigma, favor-
itism, unequal power relationships, and perceptions about the
healthiness of pregnant women (See Table 3, Key Review Finding
4a).
Negative and stigmatizing attitudes of nurses and doctors were a
common complaint of patients in many settings, regardless of the
clinical service. Women in these studies complained about the
general negative attitudes of nurses and doctors in the public
health service, as well as stigmatizing attitudes related specifically
to pregnancy, sexual behavior and HIV [18,22,23,26,41,45,54].
Besides making women feel judged and unwelcome, HIV-related
stigma among healthcare workers was also frequently perceived by
women to pose a direct threat, i.e., the possibility of confidentiality
being breached. There were widespread fears among women that
nurses, in particular, would either intentionally or unintentionally
disclose their HIV status to others in the clinic or community out
of either malice or reckless disregard [39,45].
Women in some studies also reported concern about favoritism
or nepotism among healthcare workers at their local clinic
[16,18,23]. Some indicated a preference for going to facilities
outside of their community, not only for the confidentiality
protections this might afford but also as a way to avoid social
discrimination within their local facility [18,45]. This discrimina-
tion could be family-based, religious or ethnic in nature.
Staff attitudes towards pregnant women were also shaped by
their perception of pregnancy as a state of positive health and the
behavior of pregnant women. Several of the studies reported a
more general perception that pregnant women were essentially
healthy and that when the clinic was full or resources were tight,
they could receive less attention or be asked to return on another
day [18,24,46].
In general, the studies describe a relationship between patients
and providers that is persistently highly unequal in terms of social
power. This was less true of engagements with community health
workers, with whom women generally had positive relationships
[45]. Doctor-patient relationships were highly unequal, but in
most of the settings assessed, doctors were not a frequent presence.
It was the nurse-patient relationship that received the most
attention and concern in the reviewed studies, and was most
frequently described as both asymmetrical and disempowering.
A few studies reported on positive relationships between patients
and providers. These generally found that positive relationships
resulted in dramatic differences in perceptions about the quality of
care and patient satisfaction, as well as uptake and retention in
care. Several studies, for example, reported that provider
characteristics were critical factors in HIV testing uptake, and
could be far more important than other health systems barriers,
such as long waiting times for tests or un-integrated services
[18,25,41]. These findings highlight the importance of respectful
care throughout all aspects of reproductive, maternal and HIV
service delivery.
Characteristics of effective forms of engagement. Besides
the direct, interpersonal relationship between patient and provider,
there were a number of other important forms of engagement
described in the included studies. The more effectively health
services kept women engaged with the health system, the more likely
women were to initiate and be retained in care. There were several
ways in which health systems kept HIV-infected pregnant women
engaged in maternal health and HIV care. Factors that contributed
to success of these approaches included their directness, intensity,
frequency, and extension of providers’ engagement with women
beyond the health facility (See Table 3, Key Review Finding 4b).
The power of more direct, intensive and frequent health system
engagement was a theme of several studies that reported on
women’s need for more health information and health counseling
opportunities at regular intervals. These studies argued that many
women lacked opportunities for significant one-on-one interaction
with a healthcare worker and that when these opportunities were
available, they were a critical enabler of positive maternal ART
outcomes [17,23,33,34,44]. Women were seeking health informa-
tion, as well as counseling with respect to health decision-making
and the emotional dimensions of their HIV diagnosis
[23,24,41,46]. They were often uncomfortable seeking this advice
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in group contexts, in public waiting rooms, semi-public consulta-
tion rooms, or with providers to whom they had little prior
relationship.
Repeat visits to health facilities for ANC or HIV care were
described as important predictors of initiation, retention and
adherence to ART [19,22,24,28,46]. This could be due to the fact
that repeat visits provide more opportunity for the kinds of direct
and intensive engagement described above. The direction of
causality is not necessarily clear, however, since women who
attend ANC services regularly may already be more likely to
initiate and remain adherent to ART.
Outreach efforts like home visits or SMS reminders, when not a
threat to disclosure, were described as enablers of better outcomes
if they resulted in more consistent or direct contact with women.
Several of the studies reported on a positive association between
accessing ANC care or having a facility birth and better maternal
ART outcomes, at a more general level [22,26,28,31,39]. This was
a strong and consistent association. However, there was insuffi-
cient detail as to the direction of this effect. Again, it is not clear
whether facility birth somehow produces the conditions for better,
ongoing HIV care, or whether those who have facility births are
more likely to initiate or adhere to ART. Nonetheless, there was a
consistent pattern that poor retention during ANC was associated
with poorer maternal ART outcomes, and ART initiation before
delivery was associated with better retention and adherence during
the postpartum period.
Theme 5: Interventions to Improve Maternal ART
Outcomes
This theme reviews findings related to interventions for
improving outcomes related to maternal ART. The majority of
the studies did not report on specific interventions. Some
evaluated the outcomes of new treatment protocols or models of
care but did not formally compare these outcomes to other or
previous protocols or models.
Twelve studies (29 percent), however, assessed the effectiveness
of specific interventions to improve initiation, retention and/or
adherence to ART among HIV-infected pregnant or postpartum
women [21,35,37,38,42,43,47,48,52,53,55,56]. Four of these
studies assessed newer service delivery models [42,43,53,55] and
one involved the Option B+ for PMTCT treatment protocol. [48].
Four of the studies described more discrete interventions: an SMS
support group, two ‘fast-tracking’ initiatives to increase the speed
of ART initiation, and a pilot test of simultaneous triple point-of-
care testing for HIV, syphilis and hepatitis B [21,35,37,38]. Three
studies described much more comprehensive, multi-layered efforts
to intervene across the ART cascade and within different aspects
of the health system [47,52,56]. A summary of these interventions
along with the qualitative and quantitative mechanisms and effects
reported by the studies is available in the Supporting Information.
The design of interventions, the intervention settings, the length
of study follow-up, and the ability of these studies to validly detect
differences between different models of care/interventions varied
widely. Generalizing about which interventions for maternal ART
might be most effective is, therefore, not really possible with this
set of data. However, one broad theme that can be derived from
these findings is that while there may be some potential ‘quick
wins’ in improving outcomes along the maternal ART cascade, the
most effective interventions address more than one area of
concern. These provide multi-pronged and multi-leveled inter-
ventions along the maternal ART cascade and within the broader
health system to support maternal ART initiation, retention and
adherence (See Table 3, Key Review Finding 5a).
For example, the integrated ANC and ART services for
mothers described by Wiegel et al. [43] showed dramatic
improvements in maternal ART outcomes. It is important to
note, however, that in addition to service integration, this program
involved wide-ranging interventions throughout maternal health
and ART services. The effect of the introduction of Option B+ in
Malawi on maternal ART initiation was similarly dramatic
[48,50], leading to a 748 percent increase in the number of
initiations over a one-year period. Here, too, however, the
intervention involved far more than a change in protocol (i.e.
removing the requirements for CD4 staging and starting all
pregnant women on ART when they test positive for HIV). ANC
and ART services were thoroughly decentralized and integrated,
health information systems strengthened, task shifting implement-
ed, healthcare workers were trained in the new guidelines, drug
regimens for pregnant women were changed, and there was
intensive supervision and support from a national task team.
More narrow, targeted efforts to reduce delays in movement
along the maternal ART cascade, such as ‘fast-tracking’ of ART
[35,37], also significantly improved ART uptake. Evidence about
how sustainable or widespread the impact of these more discrete
interventions may be, is not yet available.
Discussion
Maternal ART in the Changing HIV Landscape
Global efforts to scale-up universal access to HIV treatment and
care and intensify PMTCT programs continue to gain pace.
Ambitious goals of 15 million people using ART and reducing the
number of new infections in children by 90 percent by the year
2015 are gaining momentum, and there have been some
resounding successes [58]. HIV testing and ART initiation rates
are improving around the world and many programs in resource-
constrained settings are reporting retention and adherence rates
that match or surpass those in developed settings [7,59].
There are also some emerging challenges as HIV becomes a
chronic disease and the delivery of lifelong ART becomes a central
component of the ongoing work of health systems. The financial
sustainability of and political commitment to HIV and AIDS
programs, the persistent shortage in human resources for health,
and the challenges of long-term treatment adherence are of
increasing concern in this new era of massive public ART
programs [60]. These challenges will only intensify as global
policies moves towards universal treatment.
The program outcomes reported by the studies included in this
review argue for additional concern when it comes to maternal
ART. There were significant drop-outs throughout the maternal
ART cascade and the numbers of women who ended up receiving
treatment compared to those who needed it (the ‘treatment
coverage gap’) was often worse, and sometimes much worse, than
outcomes reported in general adult ART programs. It appears that
ensuring pregnant and postpartum women are enrolled, retained
and adherent on ART for their own health poses unique
challenges for health systems.
Many of the health system barriers to and enablers of maternal
ART that we identified in this review will be familiar to those
working in adult ART contexts. Problems with communication
and coordination among healthcare workers and services,
stigmatizing healthcare worker attitudes, supply chains, and poor
health information systems were common weaknesses of many
health systems. Addressing these problems is not only a priority for
the health of HIV-infected pregnant and postpartum women but is
also essential for ensuring the health of all segments of the
population. But these factors must receive particular attention if
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the global goals of scaling up ART and PMTCT programs are to
be successfully implemented.
This review identified a number of health system-related factors
that were related specifically to the experiences, needs and
vulnerabilities of pregnant and postpartum women which are of
relevance for program managers and policymakers working to
reduce HIV-related maternal deaths. Table 5 provides a summary
of the health system factors of relevance to caring for pregnant and
postpartum women.
While the studies we reviewed provided rich detail on the kinds
of health system barriers and enablers to ART that existed for
pregnant and postpartum women, we found less evidence about
the kinds of interventions that might prove successful in addressing
health system barriers [61]. There were several interventions that
showed very promising results; these tended to involve intensive,
comprehensive, and well-supported interventions. The question of
whether these interventions can be scaled and still produce similar
results remains open and urgent. Other studies that tested simpler
or shorter-term interventions in routine settings reported less
dramatic results. Another consideration when interpreting the
findings about intervention effectiveness is that most of the
available evidence comes from studies that were not designed to
carefully compare different interventions. They may not, there-
fore, on their own provide the kind of detailed and reliable
evidence needed to guide maternal ART programs and policies.
Some studies that did not fit the review inclusion criteria of
providing specific findings on health system barriers and enablers
to ART nonetheless described promising interventions for
maternal ART programs. One was a community health worker
(CHW) program in Malawi that provided more integrated care for
and sustained contact with HIV-infected pregnant and postpartum
women and reported a number of improved maternal ART and
PMTCT outcomes [62]. Another similar intervention using
CHWs in South Africa is also showing promising results [63].
Whether or not these CHW initiatives for providing support to
pregnant women during testing, ART assessment and initiation,
and retention and adherence offer a potential solution to some of
the health system barriers and enablers discussed in this paper is
an open question. An important commonality of these interven-
tions, with the successful ones included in this review is their
systems-oriented approach to health system problems and their
focus on intervening along several points of the maternal ART
cascade. This also underscores the importance of careful
evaluation to identify where along the cascade problems exist
and tailoring interventions to address the specific problems
identified.
‘Option B+’, a PMTCT treatment protocol that makes all HIV-
infected pregnant women eligible for ART regardless of CD4
count, is increasingly being adopted by many countries. This
protocol removes a critical barrier to initiation, the need for CD4
staging, and allows women to move as fast as possible from HIV
diagnosis to treatment initiation, thus, increasing their health and
survival outcomes. Only one study included in this review directly
assessed Option B+. However, it was a very brief and early report
on program outcomes. It described a fairly comprehensive
national intervention in Malawi that showed remarkable success
in initiating much greater numbers of pregnant HIV-infected
women onto ART.
The other evidence reviewed, while indirect with respect to
Option B+, provides both notes of support and caution for this
promising approach. Studies included in this review suggest that
Option B+ may be successful because of the ways it addresses the
critical drop-outs along the several steps that typically separate
HIV diagnosis and ART initiation. By simplifying the PTMCT
protocols related to CD4 staging, healthcare workers would no
longer be required to wait to receive CD4 results before initiating
ART.
Option B+, however, does not lessen the need for thinking
carefully about 1) the organization of care with regard to the
integration of HIV and ANC care; 2) how pregnant women’s
movement across and between these services can best be facilitated
to ensure they are not lost to follow up; 3) how to encourage
women to accept treatment and manage those who may not be
ready to initiate soon after diagnosis; and 4) how to ensure they are
retained in care and adherent to ART throughout their
pregnancies and postpartum.
We cannot predict how successful Option B+ programs will be
in addressing all of these challenges. It is apparent that pregnant
women will continue to present unique challenges for maternal
health, PMTCT and HIV services. It is also clear that focused
attention is warranted to ensure that their enrollment and
maintenance in HIV care is carefully and effectively integrated
throughout the complicated and vulnerable period of pregnancy
and postpartum. Option B+ will resolve some of the key obstacles
to initiating HIV-infected pregnant women onto ART, which are
a critical concern given the time-bound nature of pregnancy.
Nonetheless, many of the broader health system challenges and
concerns around maternal ART programs identified by this review
will remain relevant and will need to be answered by local
policymakers and program managers in ways appropriate to local
contexts and constraints.
Table 5. Pregnancy-Related Health Systems Factors.
PREGNANCY-RELATED HEALTH SYSTEMS BARRIERS AND ENABLERS
Challenge of coordinating HIV care for women with their movement into ANC, through the delivery and post-partum phases of care, and back into general adult
primary care
Loss of focus on pregnant women’s health needs in the context of PMTCT programs’ focus on preventing vertical transmission
The particular blind spot of the postpartum period, when women are transitioning out of ANC and PMTCT care but not are effectively linked to ongoing primary or HIV
care
Health services that are not set up to respond to the unique health and social needs of pregnant women (e.g. not sitting and waiting all day to be seen, not being
viewed (by selves and others) as ‘sick enough’ to warrant focused attention, need for movement across facilities during and after pregnancy to access social support,
difficulty in coordinating both ANC and HIV care visits, if separate)
Poor knowledge and training among healthcare workers about the importance of maternal ART, maternal ART protocols and maternal ART referral procedures
Time-bound nature of pregnancy not sufficiently accounted for in some ART protocols that required lengthy assessment and drug readiness training before initiation
doi:10.1371/journal.pone.0108150.t005
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Review Limitations and Research Gaps
Limitations of the review design and scope. The strengths
of this review’s design included its inclusive search strategy that
ensured wide coverage and the dual data extraction and iterative
analysis. There are several important limitations to note. Time
constraints prevented a more thorough and systematic search of
the gray literature, a body of evidence that may have had more to
offer with respect to Option B+ and other current maternal ART
program experiences and interventions. Time and resources
available also limited the degree of outside, expert review that
was possible and the languages that could be covered.
While time may have also restricted the degree to which we
were able to refine our analysis and further transform the data
from the included studies, it is not clear we could have done much
more beyond thematic and cross-case comparative analysis, given
the diversity of the evidence base with respect to settings, ART/
PMTCT program types and protocols, and study questions and
designs. The diversity of this evidence is a strength in terms of the
richness of data, but it was hard to identify widely generalizable
patterns or compare across studies with respect to specific program
outcomes, health system factors, or study quality.
While not a design limitation per se, the scope of the review
centered on studies reporting health system factors specifically
related to maternal ART. Much of the adult ART and PMTCT-
related literature on health system factors and potential interven-
tions would have yielded valuable lessons that might have been
transferable to the problem that was the focus of this review. This,
however, was beyond the scope of the review.
Gaps in the evidence base. Our review noted a number of
important gaps in the evidence base related to the health system
and maternal ART. Perhaps the most important gap is the women
who are not represented in the data—those who did not make it to
ANC or HIV testing in the first place, or who dropped out along
the maternal ART cascade. Given the health system-centric
nature of much of the research, we know much more about who
stayed in care and why than about those who never attended ANC
or who dropped out.
A related concern is the tendency in the studies reviewed was to
measure initiation or retention rates using a denominator drawn
from the closely preceding step in the maternal ART cascade. For
example, an initiation rate might assess the number of people who
started treatment at a clinic against those who were assessed by the
clinic as eligible for treatment. This figure, while meaningful as a
measure of effectiveness of a particular clinic, obscures other
potentially more important measures of health system function. In
these studies, the number of people who started treatment might
be compared against the total number of ART-eligible patients
who were successfully referred to assessment, or against the total
number of ART-eligible patients who received an HIV test, or
even against the total population in need, i.e. all of the HIV-
Table 6. Recommendations.
Focal Area Recommendation
Strengthening the Focus on
HIV-infected Pregnant Women
Policymakers and program managers should re-evaluate maternal ART services using the maternal ART cascade and
pathways through maternal ART care as organizing frameworks. This re-evaluation should 1) systematically diagnose
current bottlenecks and drop-out points in detail, 2) identify the health systems barriers that contribute most to these
problems, 3) identify a set of interventions that could sustainably and effectively addresses these problems, and finally, 4)
align these priority areas and intervention options with existing HIV and ANC/PMTCT services.
Policymakers, program managers and researchers should focus on understanding and addressing delays in progression
through the maternal ART cascade. Both monitoring and evaluation processes should include measures of time and its
effects more explicitly.
Attention should be renewed on the range of women who never make it to ANC or HIV care or who drop out along the
cascade. More information on who they are, why they never access care or why they drop out needs to be collected.
Interventions to recruit, retain and trace those lost to follow-up should be prioritized. Statistics documenting attrition
should include a wider range of denominators when assessing program outcomes.
Critical Interventions to Support
ART for HIV-infected Pregnant
Women
Health management information systems for maternal ART need to be improved. This requires strengthening both the
information systems themselves—especially with respect to identifying and tracking patients as they move between
different services and levels of care— as well as improving the management and use of health information for resource
allocation, intervention design, and accountability.
Potential ‘quick wins’ for addressing critical bottlenecks to maternal ART can sometimes be identified and acted on.
These could include relaxing treatment protocols to enable initiation of ART at the time of testing regardless of CD4
level, enabling task shifting, queue prioritization, aligning ANC and ART visits, and POC CD4 testing.
Opportunities to increase the directness, intensity, frequency and extension of the health system’s engagement with
pregnant HIV-infected women should be identified and pursued. This would include not only patient-provider
engagement within the health system itself but also strengthening of the facility/community continuum through the
development of coordinating and supporting interventions such as peer mentors, community health workers
coordinators, support groups, etc.
Effective and sustainable interventions to support maternal ART, however, should be multi-pronged and multi-leveled
and seek to make an impact across the cascade at both facility and higher levels of the health system.
Research Gaps and Priorities Critical gaps in the evidence base regarding maternal ART include adherence outcomes, and factoring affecting
adherence; the role of timeliness and timing as discrete variables; the barriers and enablers for those who never make it
to health services and those who drop out, and maternal ART outcomes along the full cascade and using a variety of
denominators for different comparative evaluation (e.g. ART program performance with respect to the population in care
versus ART program performance with respect to the population in need).
Program evaluations using strong, prospective research designs in pragmatic settings should be prioritized in order to
better characterize likely maternal ART outcomes and challenges in settings outside small pilot interventions.
Measures of adherence should be standardized to enable comparison across programs and studies.
doi:10.1371/journal.pone.0108150.t006
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infected and ART-eligible pregnant women in a catchment area
(many of whom never access the health system). Alternative
comparisons like these would highlight the scale and impact of
cumulative dropout along the maternal ART cascade. Measures of
dropout with a narrower frame of reference make it harder to
think broadly about the challenge of supporting pregnant women
all the way through the maternal ART cascade. Deciding on the
most relevant basis for comparison in health statistics is not only a
challenge for research but an important one for policy making,
program planning, service delivery and management since the
choices made shape the factors that are more and less visible.
Ensuring that women initiate ART and remain in care is
difficult, and the problem of long-term adherence is equally
important and complex. The review identified several weaknesses
in the evidence base that are of relevance to these challenges. The
first is the absence of evidence about long term adherence. Most of
the studies included in this review assessed initiation and a few
assessed retention in care (the easiest longitudinal variable to assess
using routine health data in clinical epidemiology studies). We
found very little on adherence. This likely reflects the broader lack
of attention to maternal ART outcomes that have been discussed
above.
The second adherence-related gap is the lack of consistent, and
thus, comparable measures of adherence across studies. In
Table 2, we reviewed the measures of adherence used in the
included studies. As with the question of which denominator to use
when assessing drop-out, unless there are measures of adherence
that are as valid, reliable and consistent as possible, it will be very
difficult for future researchers to assess this critical long-term
program outcome.
We have already noted the relative lack of well-designed,
prospective studies of maternal ART outcomes and comparisons
of models of care or other interventions in routine settings. There
is also an absence of data from outside of Southern and Eastern
Africa.
Finally, we were struck by how few studies explicitly modeled
the dimension of time as it related to movement through the
maternal ART cascade [34]. Most of the studies that assessed
factors related to drop-out mentioned timeliness (moving quickly
through the cascade) and timing (aligning phases of the pregnancy,
clinic visit schedules, and ART protocols) as critical considerations,
given the relatively short, time-defined nature of pregnancy and
the complicated steps often required to move women through both
ANC and HIV care. However, very little empirical evidence was
collected or analyzed about timeliness or timing as discrete
variables. In the absence of such information, it is not only difficult
to establish if, to what degree, and to what effect particular
interventions may speed up womens’ movement through the
cascade. It is also difficult to address potentially more complex
questions such as the optimal timing of movement through the
cascade when consider in relation to other factors that might
recommend less rapid initiation, such as poor treatment readiness
or the presence of co-morbidities in pregnant women [34,64,65].
This issue is critical since approaches like Option B+ are often
mistakenly described as interventions that inevitably reduce the
time it will take women to move through the cascade. The
simplification of PMTCT protocols and subsequent time required
to initiate treatment are often inter-related. However, it is critical
to remember that even with Option B+ in place, there could be
any number of critical barriers to initiation that significantly delay
ART initiation. Conversely, Myer et al. [35] showed that even
within the framework of Option B (ART initiation at CD4 ,350),
programs could find ways to ‘fast-track’ eligible women and enable
significantly more of them to initiate ART the same day they were
diagnosed. It, thus, seems important to give added attention to
defining and collecting data on timeliness and timing as discrete
variables in studies of maternal ART processes and outcomes.
Conclusions and Recommendations
Policy and program responses to our review findings will
inevitably need to be highly context specific. We have, therefore,
developed over-arching conclusions and recommendations to
guide this process. Table 6 presents the key conclusions from this
review in the left column and outlines a series of recommendations
in the right column that can be used to guide policymakers and
program managers in applying the findings within their local
settings.
We have drawn three over-arching conclusions from the
findings and analysis presented above. The first is the lack of
focus on the unique experiences, needs and vulnerabilities of HIV-
infected pregnant and postpartum women. Health systems need to
pay more attention to finding ways to facilitate their movement
effectively through both maternal health and HIV care. Second,
supporting the movement of these women along the maternal
ART cascade will require both a thorough diagnosis of the
relevant barriers and enablers, as well as systemic, simultaneous
interventions along several points of the cascade. This remains
critical for the development and implementation of effective
integrated HIV and maternal health services.
Finally, there are a number of critical evidence gaps and
priorities for future research that merit attention. Only by better
understanding the complex and inter-related health system
barriers and enablers that determine women’s movement through
both maternal health and HIV care can we design interventions
that will improve maternal ART initiation, retention and
adherence. This is essential for ending preventable child and
maternal deaths and achieving an AIDS-free generation.
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